Portfolio of Diabetes Stocks
Here is a sample of 12 stocks that provide diabetes treatments and monitoring.
| 12 Diabetes Stocks | ||
|---|---|---|
Name | Symbol | Recent Prices |
| Abbott Laboratories | ABT | |
| AstraZeneca | AZN | |
| DexCom | DXCM | |
| Eli Lilly | LLY | |
| Insulet Corporation | PODD | |
| Lexicon Pharmaceuticals | LXRX | |
| MannKind Corp. | MNKD | |
| Medtronic | MDT | |
| Novo Nordisk | NVO | |
| Provention Bio | PRVB | |
| Senseonics Holdings | SENS | |
| Tandem Diabetes Care | TNDM | |
| Sparkline weekly price charts based on Alpha Vantage data. | ||
| 12 Diabetes Stocks | ||
|---|---|---|
Name | Symbol | Last Close |
| Abbott Laboratories | ABT | $96.76 |
| AstraZeneca | AZN | $54.84 |
| DexCom | DXCM | $80.54 |
| Eli Lilly | LLY | $323.35 |
| Insulet Corporation | PODD | $229.40 |
| Lexicon Pharmaceuticals | LXRX | $2.40 |
| MannKind Corp. | MNKD | $3.09 |
| Medtronic | MDT | $80.75 |
| Novo Nordisk | NVO | $99.63 |
| Provention Bio | PRVB | $4.50 |
| Senseonics Holdings | SENS | $1.32 |
| Tandem Diabetes Care | TNDM | $47.85 |
Portfolio Values
To inspect the performance of the Diabetes Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.The 11 stocks included in the portfolio computations are: ABT, AZN, DXCM, LLY, PODD, LXRX, MNKD, MDT, NVO, SENS and TNDM. The current value of the portfolio assumes that $909.09 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. PRVB was excluded from the portfolio computations because of insufficient price data.The current value of the $10,000 investment is $27,999. The percent return is 179.99%. The annualized return is 22.87%.
| 11 Diabetes Stocks Returns | ||
|---|---|---|
Name | Symbol | Monthly Returns & Details |
| Abbott Laboratories | ABT | 96.86% |
| AstraZeneca | AZN | 88.20% |
| DexCom | DXCM | 558.48% |
| Eli Lilly | LLY | 317.44% |
| Insulet Corporation | PODD | 316.49% |
| Lexicon Pharmaceuticals | LXRX | -80.47% |
| MannKind Corp. | MNKD | 42.40% |
| Medtronic | MDT | 16.42% |
| Novo Nordisk | NVO | 127.27% |
| Senseonics Holdings | SENS | -58.62% |
| Tandem Diabetes Care | TNDM | 555.48% |
Portfolio Value Chart for Last 100 Daily Closes